Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Doctoral: Vanier Canada Graduate Scholarships

McGill University

$150,000.00

Partnering with Patients to Build an Evidence Base on the Best Methods for Communicating Research Results to Patients: A "Living" Evidence Synthesis and Series of "Learning" Trials

EF 2024-25

Résumé
Supervisor: Dr. Brett Thombs, McGill University. What is my research about? I aim to identify the most effective methods for communicating research results to patients, a crucial yet challenging task for many researchers. Why is my research important? Effective communication about research can foster trust in science, empower patients to be well-informed healthcare consumers, and minimize misunderstanding and misapplication of research. What methods are used to communicate research to patients? Various tools, like lay abstracts, news articles, infographics, podcasts, videos, and websites, are used. However, very few studies have directly compared them. How will I conduct my research? My research has two parts. (1) I will conduct a series of trials with over 1,500 people living with the rare autoimmune disease scleroderma, all part of an established international cohort. In each trial, I will randomly assign participants to different email-delivered tools that communicate results from a recent scleroderma study. Each trial will help identify which tools most effectively convey information, cover desired topics, and are user-friendly. I will also assess whether certain tools perform better for different groups based on factors like gender, age, race or ethnicity, and education. (2) Simultaneously, I will conduct an ongoing review to summarize results from all existing trials, including mine, that compare tools. This effort will provide researchers with the latest evidence. Who is involved in my research? A diverse team of 12 people with scleroderma and multi-disciplinary researchers co-developed my research approach and will be involved in all aspects of it. What is expected from my research? My work will help guide researchers in effectively communicating their results to patients and members of the public, thereby strengthening trust in science and empowering patients.
Programme
Doctoral: Vanier Canada Graduate Scholarships
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
517189
Name
Nassar Elsa-Lynn
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Health Services and Policy Research
Theme2
Health systems / services
Prcname2
Vanier Canada Graduate Scholarships CIHR
Projecttitle
Partnering with Patients to Build an Evidence Base on the Best Methods for Communicating Research Results to Patients: A "Living" Evidence Synthesis and Series of "Learning" Trials
Programtype2
Studentship Programs
Orgnameinp2
McGill University
Cihramount2
$150,000
Cihrequipment2
$0
Programname2
Doctoral: Vanier Canada Graduate Scholarships
Keyworddelim
Cohort-Based Trials; Knowledge Dissemination; Knowledge Translation; Patient Communication; Patient Engagement; Patient-Partnered Research; Randomized Controlled Trials; Scleroderma; Systematic Review; Systemic Sclerosis
Abstract
Supervisor: Dr. Brett Thombs, McGill University. What is my research about? I aim to identify the most effective methods for communicating research results to patients, a crucial yet challenging task for many researchers. Why is my research important? Effective communication about research can foster trust in science, empower patients to be well-informed healthcare consumers, and minimize misunderstanding and misapplication of research. What methods are used to communicate research to patients? Various tools, like lay abstracts, news articles, infographics, podcasts, videos, and websites, are used. However, very few studies have directly compared them. How will I conduct my research? My research has two parts. (1) I will conduct a series of trials with over 1,500 people living with the rare autoimmune disease scleroderma, all part of an established international cohort. In each trial, I will randomly assign participants to different email-delivered tools that communicate results from a recent scleroderma study. Each trial will help identify which tools most effectively convey information, cover desired topics, and are user-friendly. I will also assess whether certain tools perform better for different groups based on factors like gender, age, race or ethnicity, and education. (2) Simultaneously, I will conduct an ongoing review to summarize results from all existing trials, including mine, that compare tools. This effort will provide researchers with the latest evidence. Who is involved in my research? A diverse team of 12 people with scleroderma and multi-disciplinary researchers co-developed my research approach and will be involved in all aspects of it. What is expected from my research? My work will help guide researchers in effectively communicating their results to patients and members of the public, thereby strengthening trust in science and empowering patients.
Competitiondate
202410
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Nassar, Elsa-Lynn
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $150,000~ $0~